ArticlePloS one2026
Chronic kidney disease progression rate and predictors in hypertensive patients: A 5-year retrospective follow-up study in Ethiopia.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChronic kidney disease is a major public health concern worldwide. Despite the well-established link between hypertension and chronic kidney disease, early detection and management of chronic kidney disease among hypertension patients in primary healthcare settings remain inadequate. Moreover, studies on the progression and predictors of chronic kidney disease among hypertensive individuals in Ethiopia, particularly in the study area, are limited. Therefore, this study aimed to assess chronic kidney disease progression rate, incidence, and predictors among hypertensive patients in South Gondar Zone hospitals in Ethiopia.
methodsA retrospective follow-up study was conducted among the medical records of 510 hypertensive patients in South Gondar Zone hospitals, North West Ethiopia, from September 2019 to June 2024, which was selected through simple random sampling technique. Data were collected via a structured checklist with an Android-based Kobo collection toolbox from the medical charts. EPI data version 4.2 and STATA version 17 were used for data entry and analysis. Kaplan‒Meier, log-rank tests, and a Cox proportional hazard regression model were used for data analysis.
resultProgression to chronic kidney disease occurred at a median of 46 months (IQR:37-55) in hypertension patients. The incidence rate of chronic kidney disease among hypertensive patients was 9.45 (95% CI: 8.07, 11.01) per 1000 person-month observations. Uncontrolled blood pressure (AHR = 1.52, 95% CI: 1.05-2.20), obesity (AHR = 2.56, 95%CI: 1.63-4.01), and high triglyceride levels (AHR = 1.72, 95%CI: 1.03-2.91) were significant predictors of rapid progression of chronic kidney disease among hypertensive patients as compared with their counterparts. CONCLUSION AND RECOMMENDATION: Hypertensive patients in this study progressed to chronic kidney disease more rapidly as compared to other studies. This could be explained by obesity, uncontrolled blood pressure, and high triglyceride levels. Routine screening of triglyceride levels and lifestyle modifications that target obesity reduction and impact blood pressure control is recommended.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.